About Ketamine Path
Independent, journey-focused writing about ketamine therapy — with citations, monitoring boundaries, and explicit uncertainty.
Our editorial standard
What this site is
Ketamine Path is an independent reference site that walks you through ketamine therapy as a decision: when it is worth considering, what to ask, and how to evaluate the option in front of you.
What this site is not
Ketamine Path is not a clinic, telehealth provider, or referral service. We do not diagnose, prescribe, or treat. Articles here describe how ketamine therapy is studied and used; they do not replace evaluation by a qualified clinician.
How we write
- Each long-form article cites the primary literature it relies on.
- We separate FDA-approved esketamine from off-label racemic ketamine because the evidence and regulatory status differ.
- We surface monitoring expectations alongside the dosing discussion.
- We update articles when new evidence materially changes the picture, and date the last review.
Disclosures
We accept no payment from clinics, manufacturers, or telehealth providers in exchange for coverage. The advertising page describes the few ways the site is supported.
Editorial corrections welcome
If you find an error or believe an article needs updating in light of new evidence, please write to us — we treat every correction request seriously.
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.